Corrigendum and Editorial Warning Regarding Use of the MMAS-8 Scale (A Remote Medication Monitoring System for Chronic Heart Failure Patients to Reduce Readmissions: A Two-Arm Randomized Pilot Study)

Possible gift authorship and undeclared conflict of interest in: “Effect of self‐administration of medication programme on cardiovascular inpatients' medication adherence and nurses' satisfaction: A randomized clinical trial. Nursing Open 2021: 8(4):1947–1957.”

“…In the corrigendum, the MMAS was removed from the paper and an alternative adherence measure added. The editor warned researchers: “the developers of this scale are known to comb the literature and ask those who used the scale for research to pay for a retroactive license which may cost thousands or tens of thousands of dollars, and to add references to their work” (Hale et al., 2019 ).…”

“…Marcus, 2021). There are also numerous case examples of researchers that have used the MMAS-without permission-receiving demands for money or immediate retraction of the paper: Hale et al (2019) have reported a corrigendum and editorial warning about the MMAS. The authors and the Journal of Medical Internet Research editors were forced to issue the correction because of legal threats by Dr Morisky (Hale et al, 2019).…”

“…There are also numerous case examples of researchers that have used the MMAS-without permission-receiving demands for money or immediate retraction of the paper: Hale et al (2019) have reported a corrigendum and editorial warning about the MMAS. The authors and the Journal of Medical Internet Research editors were forced to issue the correction because of legal threats by Dr Morisky (Hale et al, 2019). The original paper reported the results of a trial of a remote medication monitoring system for heart failure patients, and the MMAS was one of the adherence measures used in the study (Hale et al, 2016).…”

Corrigendum and Editorial Warning Regarding Use of the MMAS Scale (The Ready to Reduce Risk (3R) Study for a Group Educational Intervention With Telephone and Text Messaging Support to Improve Medication Adherence for the Primary Prevention of Cardiovascular Disease: Protocol for a Randomized Controlled Trial)

“…This is unfortunately not an isolated case, as the developers of this scale are known to comb the literature and ask those who used the scale for research to pay for a retroactive license which may cost thousands or tens of thousands of dollars, and to add references to their work [1]. This is now the fourth correction JMIR has to publish related to studies using the MMAS instrument [2-4].…”

Corrigendum and Editorial Warning Regarding Use of the MMAS Scale (The Ready to Reduce Risk (3R) Study for a Group Educational Intervention With Telephone and Text Messaging Support to Improve Medication Adherence for the Primary Prevention of Cardiovascular Disease: Protocol for a Randomized Controlled Trial) (Preprint)

“…This is unfortunately not an isolated case, as the developers of this scale are known to comb the literature and ask those who used the scale for research to pay for a retroactive license which may cost thousands or tens of thousands of dollars, and to add references to their work [1]. This is now the fourth correction JMIR has to publish related to studies using the MMAS instrument [2][3][4].…”